A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs).

Effective delivery of transgenes to the brain through a non-invasive route has great prospects for treating diseases in the central nervous system (CNS). Slightly anionic pegylated immunoliposomes (PILs) have been shown to be effective in reaching the CNS, but efficient DNA encapsulation into the liposomes used for this purpose is technically difficult and hard to reproduce. We here use an improved protocol for DNA encapsulation of pegylated immunoliposomes based on ethanol-mediated DNA condensation. We introduce a dialysis step following DNA encapsulation to remove ethanol and show that this step is necessary to ensure complete nucleolytic removal of non-encapsulated DNA. The uptake of the pegylated immunoliposomes into human cells was documented by live-cell confocal imaging, and specific targeting to the human insulin receptor was shown by inhibiting clathrin-mediated endocytosis.

[1]  P. Lybaert,et al.  Evidence for a Clathrin-Mediated Recycling of Albumin in Human Term Placenta1 , 2006, Biology of reproduction.

[2]  M. Bally,et al.  Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. , 2000, Journal of pharmaceutical sciences.

[3]  A. Dautry‐Varsat,et al.  Rapid endocytosis of interleukin 2 receptors when clathrin‐coated pit endocytosis is inhibited , 1994, Journal of cell science.

[4]  W. Pardridge,et al.  Intravenous glial‐derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter , 2008, The journal of gene medicine.

[5]  W. Pardridge,et al.  Lysosomal Enzyme Replacement of the Brain with Intravenous Non-Viral Gene Transfer , 2008, Pharmaceutical Research.

[6]  K. Longmuir,et al.  Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid. , 2001, Nucleic acids research.

[7]  L. Jeffs,et al.  A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA , 2005, Pharmaceutical Research.

[8]  W. Pardridge,et al.  Widespread expression of an exogenous gene in the eye after intravenous administration. , 2002, Investigative ophthalmology & visual science.

[9]  W. Pardridge,et al.  Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomes , 2007, The journal of gene medicine.

[10]  R. G. Anderson,et al.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.

[11]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[12]  Joseph Kost,et al.  Modified pectin-based carrier for gene delivery: cellular barriers in gene delivery course. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  W. Pardridge,et al.  Marked enhancement in gene expression by targeting the human insulin receptor , 2003, The journal of gene medicine.

[14]  Jian Yi Li,et al.  Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. , 2003, Molecular vision.

[15]  S. M. Sullivan,et al.  Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. , 2000, Biochimica et biophysica acta.

[16]  F. Liu,et al.  Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration , 1997, Gene Therapy.

[17]  K. Braeckmans,et al.  Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  D. Heistad,et al.  Endocytosis of Extracellular Superoxide Dismutase Into Endothelial Cells: Role of the Heparin-Binding Domain , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Hashida,et al.  Interaction between DNA–cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid , 2001, Gene Therapy.

[20]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[21]  W. Pardridge,et al.  Absence of Toxicity of Chronic Weekly Intravenous Gene Therapy with Pegylated Immunoliposomes , 2003, Pharmaceutical Research.

[22]  N. M. Rao,et al.  Quantitative aspects of endocytic activity in lipid‐mediated transfections , 2005, FEBS letters.

[23]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[24]  F. Calon,et al.  Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.

[25]  W. Pardridge,et al.  CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport , 1998, Journal of neurochemistry.

[26]  W. Pardridge,et al.  Brain-specific expression of an exogenous gene after i.v. administration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Pardridge,et al.  Noninvasive gene targeting to the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Pardridge,et al.  Receptor-Mediated Gene Targeting to Tissues In Vivo Following Intravenous Administration of Pegylated Immunoliposomes , 2001, Pharmaceutical Research.

[29]  K. Siddle,et al.  Internalization of the human insulin receptor. The insulin-independent pathway. , 1992, The Journal of biological chemistry.

[30]  K. Mechtler,et al.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Dean,et al.  Effects of exogenous amines on mammalian cells, with particular reference to membrane flow. , 1984, The Biochemical journal.

[32]  P. Luisi,et al.  Entrapment of nucleic acids in liposomes. , 1997, Biochimica et biophysica acta.

[33]  W. Pardridge,et al.  Receptor‐mediated delivery of an antisense gene to human brain cancer cells , 2002, The journal of gene medicine.

[34]  M. Hope,et al.  Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. , 2002, Biochimica et biophysica acta.

[35]  H. Lee,et al.  Immunoliposomes carrying plasmid DNA: preparation and characterization , 2004, Archives of pharmacal research.

[36]  D. Pisetsky,et al.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. , 1991, Journal of immunology.

[37]  G. Lukács,et al.  Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus. , 2006, Human gene therapy.

[38]  J. Kim,et al.  Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes , 2008, Cancer Gene Therapy.

[39]  F. Calon,et al.  Novel Liposomal Formulation for Targeted Gene Delivery , 2007, Pharmaceutical Research.

[40]  Evgeny Polushkin,et al.  Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  W. Pardridge,et al.  Organ‐specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice , 2004, The journal of gene medicine.

[42]  P. Cullis,et al.  Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. , 2001, Biophysical journal.

[43]  J. Hagstrom,et al.  Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Cullis,et al.  Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. , 2001, Biochimica et biophysica acta.